Advertisement
Greater Bay Area
BusinessChina Business

Former finance chief Antony Leung’s New Frontier buys Hong Kong cancer centre as it eyes expansion in Greater Bay Area

  • New Frontier, chaired by Hong Kong’s former financial secretary, said it has bought the Hong Kong Integrated Oncology Centre
  • ‘Through this partnership, surgeons, oncologists, and other health specialists will create a nationwide multidisciplinary cancer network,’ New Frontier says

Reading Time:2 minutes
Why you can trust SCMP
The group’s major goal was to establish ‘a mutually complementary cancer treatment landscape’ in the bay area to benefit more cancer patients, said Leung, pictured. Photo: SCMP Pictures
Meredith Chen
New Frontier, chaired by Hong Kong’s former financial secretary, said it has completed the acquisition of a leading cancer treatment centre in Hong Kong as part of its expansion drive in the healthcare industry of the Greater Bay Area.
Advertisement
The investment group has bought the Hong Kong Integrated Oncology Centre (HKIOC) which, together with New Frontier’s Heal Oncology Centre in Central, will become one of the largest private oncology entities in the city, according to co-founder and chairman Antony Leung Kam-chung. He did not disclose the acquisition price.
As New Frontier will own HKIOC’s operations, its two oncology platforms in Hong Kong and its Beijing-based United Family Healthcare (UFH), which operates two private hospitals in Shenzhen and Guangzhou, will work together to elevate cross-border cancer care, the company said in a statement on Thursday.

“Through this partnership, surgeons, oncologists, and other allied health specialists will create a nationwide multidisciplinary cancer network,” New Frontier said.

The group’s major goal was to establish “a mutually complementary cancer treatment landscape” in the bay area to benefit more cancer patients, said Leung at a press event announcing the deal. In doing so, both Hong Kong and mainland China’s advantages could be leveraged to great effect.

03:44

Potential carcinogens in almost 90% of instant noodles tested, Hong Kong consumer watchdog finds

Potential carcinogens in almost 90% of instant noodles tested, Hong Kong consumer watchdog finds

Hong Kong, as a healthcare innovation hub, has easier access to cutting-edge drugs, international medical talent and innovative treatment solutions, while mainland China’s government-led centralised drug procurement has price advantages, Leung explained.

Advertisement